Activation of tumor-promoting type 2 macrophages by EGFR-targeting antibody cetuximab.
Pander J, Heusinkveld M, van der Straaten T, Jordanova ES, Baak-Pablo R, Gelderblom H, Morreau H, van der Burg SH, Guchelaar HJ, van Hall T.
Pander J, et al.
Clin Cancer Res. 2011 Sep 1;17(17):5668-73. doi: 10.1158/1078-0432.CCR-11-0239. Epub 2011 Jul 25.
Clin Cancer Res. 2011.
PMID: 21788356